BeStock  
Stocks › Biotechnology › KYMR

Kymera Therapeutics KYMR

US equityMarket cap rank #1426Biotechnology
$115.31 −$4.08 (-3.42%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $124.06 +7.59%
Open$117.89
Prev close$119.39
Day range$114.40 – $119.60
Volume1.28M
Market cap$9.84B
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±4.8%last 16 reports
Closed higher9 of 1656% of the time
Best reaction+11.1%
Worst reaction-15.1%

Stock move on the day after each report

+4.7%2023/Q4+0.2%2024/Q1-2.7%2024/Q2-3.1%2024/Q3-14.5%2024/Q4-2.3%2025/Q1-7.2%2025/Q2+0.3%2025/Q3+4.8%2025/Q4-0.5%2026/Q1+1.0%2026/Q2+0.1%2026/Q3
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q329 Oct 2026Pre Market±19.6%+0.07%Within range
2026/Q25 Aug 2026Pre Market±10.0%+1.04%Within range
2026/Q130 Apr 2026Pre Market±10.1%-0.54%Within range
2025/Q426 Feb 2026Pre Market±11.5%+4.80%Within range
2025/Q34 Nov 2025Pre Market±15.7%+0.32%Within range
2025/Q211 Aug 2025Pre Market±19.3%-7.24%Within range
2025/Q19 May 2025Pre Market±23.7%-2.27%Within range
2024/Q427 Feb 2025Pre Market±18.7%-14.45%Within range
2024/Q331 Oct 2024Pre Market±18.7%-3.15%Within range
2024/Q27 Aug 2024Pre Market±22.9%-2.68%Within range
2024/Q12 May 2024Pre Market±13.7%+0.17%Within range
2023/Q422 Feb 2024Pre Market–+4.71%–
2023/Q32 Nov 2023Pre Market–+4.59%–
2023/Q23 Aug 2023Pre Market±14.2%+11.07%Within range
2023/Q14 May 2023Pre Market±26.3%-15.08%Within range
2022/Q423 Feb 2023Pre Market±14.9%+5.17%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Latest reported quarter: Q3, ended Sep 2026

Revenue$0.00-100.0% YoY
Operating profit-$147.23M-66.1% YoY
Net profit-$132.00M-60.6% YoY
Diluted EPS-$1.32-40.4% YoY
Free cash flow-$78.23M-186.6% YoY
Operating cash flow-$77.91M

Revenue, last 8 quarters

$7.4MDec '24$22.1MMar '25$11.5MJun '25$2.8MSep '25$2.9MDec '25$34.4MMar '26$65.0MJun '26$0.0Sep '26

Net profit, last 8 quarters

$-70.8MDec '24$-65.6MMar '25$-76.6MJun '25$-82.2MSep '25$-87.0MDec '25$-69.2MMar '26$-61.2MJun '26$-132.0MSep '26

Profitability & balance sheet

Operating margin-396.0%
Net margin-341.8%
Return on equity-27.3%
Return on assets-24.4%
Return on invested capital-29.8%
Current ratio11.13
Liabilities / assets8.6%
Cash & investments$971.21M
Total debt$63.02M
Net cash (debt)$908.20M

Discussion

No comments yet — be the first to weigh in on KYMR.

Sign in to join the discussion.

Scroll to Top